Hans Jörg Reinhardt is a German businessperson who has been at the helm of 9 different companies. Presently, he is Independent Non-Executive Chairman of Novartis AG, Chairman of Novartis, Inc., Chairman-Supervisory Board of Novartis International AG, Chairman at Novartis Institutes for Biomedical Research, Inc. and Chairman-Supervisory Board at Novartis Pharma AG (which are all subsidiaries of Novartis AG) and Chairman at Institute of Molecular & Clinical Ophthalmology Basel. Hans Jörg Reinhardt is also on the board of Swiss Re AG and Chairman of Novartis Foundation and Council Member at International Federation of Pharmaceutical Manufacturers.
In his past career Dr. Reinhardt occupied the position of Chairman of Genomics Institute of The Novartis Research Foundation, Chief Operating Officer at Novartis AG and Head-Development at Sandoz Pharmaceuticals AG (a subsidiary of Novartis AG) and Chairman-Management Board at Bayer HealthCare AG.
Hans Jörg Reinhardt received a doctorate from Universität des Saarlandes.